Showing results (1-10 of 267) with videos related to

Sort By:
Pageof 27
International Journal of Molecular Sciences|November 13, 2021
Gender Differences and Immunotherapy Outcome in Advanced Lung CancerTiziana Vavalà, Annamaria Catino, Pamela Pizzutilo, et al.
Recenti Progressi in Medicina|January 29, 2021
[Efficacy of pralsetinib in a patient with advanced lung adenocarcinoma positive for RET rearrangement: the importance of Comprehensive Genomic Profiling.]Michele Montrone, Vito Longo, Annamaria Catino, et al.
Thoracic Cancer|November 5, 2022
Prognostic factors for survival in extensive-stage small cell lung cancer: An Italian real-world retrospective analysis of 244 patients treated over the last decadeVito Longo, Pamela Pizzutilo, Annamaria Catino, et al.
Thoracic Cancer|May 19, 2021
Successful treatment of triple EGFR mutation T785A/L861Q/H297_E298 with afatinibVito Longo, Annamaria Catino, Michele Montrone, et al.
International Journal of Molecular Sciences|October 23, 2021
What Are the Biomarkers for Immunotherapy in SCLC?Vito Longo, Annamaria Catino, Michele Montrone, et al.
Thoracic Cancer|September 25, 2024
Successful treatment of a non-small-cell lung cancer patient harboring HIP1-ALK (H28:A20) and CTNNB1 p.S45del with alectinibVito Longo, Francesco Pesola, Rosanna Lacalamita, et al.
Journal of Clinical Medicine|March 11, 2023
Immunotherapy in Elderly Patients Affected by Non-Small Cell Lung Cancer: A Narrative ReviewMichele Montrone, Gerardo Rosati, Vito Longo, et al.
International Journal of Molecular Sciences|March 28, 2024
Treatment of Thoracic SMARCA4-Deficient Undifferentiated Tumors: Where We Are and Where We Will GoVito Longo, Annamaria Catino, Michele Montrone, et al.
Thoracic Cancer|October 5, 2022
Controversial role of mast cells in NSCLC tumor progression and angiogenesisVito Longo, Annamaria Catino, MIchele Montrone, et al.
Thoracic Cancer|March 4, 2023
Safety evaluation of immune checkpoint inhibitors combined with chemotherapy for the treatment of small cell lung cancer: A meta-analysis of randomized controlled trialsVito Longo, Alessandro Rizzo, Annamaria Catino, et al.
Pageof 27